• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-802-5p是糖尿病肾病中的关键调节因子。

miR-802-5p is a key regulator in diabetic kidney disease.

作者信息

Kiyanpour Farnoush, Abedi Maryam, Gheisari Yousof

机构信息

Department of Bioinformatics, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Regenerative Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

J Res Med Sci. 2023 May 29;28:43. doi: 10.4103/jrms.jrms_702_22. eCollection 2023.

DOI:10.4103/jrms.jrms_702_22
PMID:37405075
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10315408/
Abstract

BACKGROUND

Diabetic kidney disease has substantial burden and limited therapeutic options. An inadequate understanding of the complex gene regulatory circuits underlying this disorder contributes to the insufficiency of current treatment strategies. MicroRNAs (miRNAs) play a crucial role as regulators of functionally related gene networks. Previously, mmu-mir-802-5p was identified as the sole dysregulated miRNA in both the kidney cortex and medulla of diabetic mice. This study aims to investigate the role of miR-802-5p in diabetic kidney disease.

MATERIALS AND METHODS

The validated and predicted targets of miR-802-5p were identified using miRTarBase and TargetScan databases, respectively. The functional role of this miRNA was inferred using gene ontology enrichment analysis. The expression of miR-802-5p and its selected targets were assessed by qPCR. The expression of the angiotensin receptor (Agtr1a) was measured by ELISA.

RESULTS

miR-802-5p exhibited dysregulation in both the kidney cortex and medulla of diabetic mice, with two- and four-fold over-expressions, respectively. Functional enrichment analysis of the validated and predicted targets of miR-802-5p revealed its involvement in the renin-angiotensin pathway, inflammation, and kidney development. Differential expression was observed in the Pten transcript and Agtr1a protein among the examined gene targets.

CONCLUSION

These findings suggest that miR-802-5p is a critical regulator of diabetic nephropathy in the cortex and medulla compartments, contributing to disease pathogenesis through the renin-angiotensin axis and inflammatory pathways.

摘要

背景

糖尿病肾病负担沉重且治疗选择有限。对该疾病潜在的复杂基因调控回路认识不足导致了当前治疗策略的不足。微小RNA(miRNA)作为功能相关基因网络的调节因子发挥着关键作用。此前,mmu - mir - 802 - 5p被确定为糖尿病小鼠肾皮质和髓质中唯一失调的miRNA。本研究旨在探讨miR - 802 - 5p在糖尿病肾病中的作用。

材料与方法

分别使用miRTarBase和TargetScan数据库鉴定miR - 802 - 5p的已验证和预测靶点。通过基因本体富集分析推断该miRNA的功能作用。采用qPCR评估miR - 802 - 5p及其选定靶点的表达。通过ELISA检测血管紧张素受体(Agtr1a)的表达。

结果

miR - 802 - 5p在糖尿病小鼠的肾皮质和髓质中均表现出失调,分别有两倍和四倍的过表达。对miR - 802 - 5p的已验证和预测靶点进行功能富集分析,发现其参与肾素 - 血管紧张素途径、炎症和肾脏发育。在所检测的基因靶点中,Pten转录本和Agtr1a蛋白存在差异表达。

结论

这些发现表明miR - 802 - 5p是糖尿病肾病皮质和髓质部分的关键调节因子,通过肾素 - 血管紧张素轴和炎症途径促进疾病发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a7/10315408/fec29890d683/JRMS-28-43-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a7/10315408/471e8890d51e/JRMS-28-43-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a7/10315408/fec29890d683/JRMS-28-43-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a7/10315408/471e8890d51e/JRMS-28-43-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a7/10315408/fec29890d683/JRMS-28-43-g002.jpg

相似文献

1
miR-802-5p is a key regulator in diabetic kidney disease.微小RNA-802-5p是糖尿病肾病中的关键调节因子。
J Res Med Sci. 2023 May 29;28:43. doi: 10.4103/jrms.jrms_702_22. eCollection 2023.
2
The regulatory axis is important for sepsis-induced acute kidney injury.调控轴对于脓毒症引起的急性肾损伤很重要。
Ren Fail. 2019 Nov;41(1):955-966. doi: 10.1080/0886022X.2019.1669460.
3
Identification of key microRNAs, transcription factors and genes associated with congenital obstructive nephropathy in a mouse model of megabladder.在巨膀胱小鼠模型中鉴定与先天性梗阻性肾病相关的关键微小RNA、转录因子和基因。
Gene. 2018 Apr 15;650:77-85. doi: 10.1016/j.gene.2018.01.063. Epub 2018 Feb 2.
4
Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.基于网络药理学的黄芪治疗糖尿病肾病的 miRNA 表达研究。
Medicine (Baltimore). 2022 Feb 4;101(5):e28747. doi: 10.1097/MD.0000000000028747.
5
Circulating miR-155-5p as a Novel Biomarker of Lumbar Degenerative Disc Disease.循环 miR-155-5p 作为腰椎退行性椎间盘疾病的新型生物标志物。
Spine (Phila Pa 1976). 2020 May 1;45(9):E499-E507. doi: 10.1097/BRS.0000000000003322.
6
MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.透明细胞肾细胞癌中的 microRNA 表达谱分析:关键 microRNA 的鉴定与功能验证
PLoS One. 2015 May 4;10(5):e0125672. doi: 10.1371/journal.pone.0125672. eCollection 2015.
7
Diabetes induces dysregulation of microRNAs associated with survival, proliferation and self-renewal in cardiac progenitor cells.糖尿病可诱导与心脏祖细胞的存活、增殖和自我更新相关的 microRNAs 失调。
Diabetologia. 2021 Jun;64(6):1422-1435. doi: 10.1007/s00125-021-05405-7. Epub 2021 Mar 2.
8
MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.miRNA 谱分析揭示骨化性纤维瘤中失调的 microRNAs 及其靶基因调控网络。
J Oral Pathol Med. 2018 Jan;47(1):78-85. doi: 10.1111/jop.12650. Epub 2017 Nov 1.
9
Microrna Expression Profiling of Macrophage Line Raw264.7 Infected by Candida Albicans.白色念珠菌感染的巨噬细胞系Raw264.7的微小RNA表达谱分析
Shock. 2017 Apr;47(4):520-530. doi: 10.1097/SHK.0000000000000766.
10
Analysis of Differentially Expressed MicroRNAs in OVA-induced Airway Remodeling Model Mice.OVA 诱导的气道重塑模型小鼠差异表达 microRNAs 的分析。
Iran J Allergy Asthma Immunol. 2022 Oct 26;21(5):524-536. doi: 10.18502/ijaai.v21i5.11040.

引用本文的文献

1
The Role of miR-802 in Diabetic Kidney Disease: Diagnostic and Therapeutic Insights.miR-802在糖尿病肾病中的作用:诊断与治疗见解
Int J Mol Sci. 2025 Jun 7;26(12):5474. doi: 10.3390/ijms26125474.

本文引用的文献

1
Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice.BTBR Ob/Ob小鼠2型糖尿病肾病中的肾脏微小RNA表达模式
Front Pharmacol. 2022 Mar 16;13:778776. doi: 10.3389/fphar.2022.778776. eCollection 2022.
2
Systems biology and machine learning approaches identify drug targets in diabetic nephropathy.系统生物学和机器学习方法鉴定糖尿病肾病的药物靶点。
Sci Rep. 2021 Dec 6;11(1):23452. doi: 10.1038/s41598-021-02282-3.
3
miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions.
miRTarBase 更新 2022:一个经过实验验证的 miRNA-靶标相互作用的信息资源。
Nucleic Acids Res. 2022 Jan 7;50(D1):D222-D230. doi: 10.1093/nar/gkab1079.
4
Small RNA sequencing evaluation of renal microRNA biomarkers in dogs with X-linked hereditary nephropathy.犬 X 连锁遗传性肾病微小 RNA 生物标志物的小 RNA 测序评估。
Sci Rep. 2021 Aug 31;11(1):17437. doi: 10.1038/s41598-021-96870-y.
5
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment.糖尿病肾病:发病机制、诊断和治疗的挑战。
Biomed Res Int. 2021 Jul 8;2021:1497449. doi: 10.1155/2021/1497449. eCollection 2021.
6
Perspectives on the role of PTEN in diabetic nephropathy: an update.PTEN 在糖尿病肾病中的作用研究进展。
Crit Rev Clin Lab Sci. 2020 Nov;57(7):470-483. doi: 10.1080/10408363.2020.1746735. Epub 2020 Apr 20.
7
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家慢性肾脏病负担,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.
8
A systematic integrative approach reveals novel microRNAs in diabetic nephropathy.一种系统的综合方法揭示了糖尿病肾病中的新型微小RNA。
J Res Med Sci. 2020 Jan 20;25:1. doi: 10.4103/jrms.JRMS_289_19. eCollection 2020.
9
miR-1 and miR-802 regulate mesenchymal-epithelial transition during kidney development by regulating Wnt-4/β-catenin signaling.微小RNA-1和微小RNA-802通过调节Wnt-4/β-连环蛋白信号通路,在肾脏发育过程中调控间充质-上皮转化。
Am J Transl Res. 2019 Nov 15;11(11):7000-7008. eCollection 2019.
10
The biochemical basis of microRNA targeting efficacy.miRNA 靶向疗效的生化基础。
Science. 2019 Dec 20;366(6472). doi: 10.1126/science.aav1741. Epub 2019 Dec 5.